Brief: ARYA Sciences Says Nautilus Biotechnology To List On Nasdaq Through Merger With Co

Nautilus Biotechnology

08/02/2021 12:24

Feb 8 (Reuters) - ARYA Sciences Acquisition III Corp
 ARYA.O :
    * NEXT-GEN PROTEOMICS COMPANY NAUTILUS BIOTECHNOLOGY TO LIST
ON
NASDAQ THROUGH MERGER WITH ARYA SCIENCES ACQUISITION CORP III
    * ARYA SCIENCES ACQUISITION III CORP - DEAL IMPLIES NAUTILUS
BIOTECHNOLOGY EQUITY VALUE OF $900 MILLION
    * ARYA SCIENCES ACQUISITION III CORP - COMBINED COMPANY IS
EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL "NAUT"
    * ARYA SCIENCES ACQUISITION III CORP - NAUTILUS
BIOTECHNOLOGY IS
EXPECTED TO RECEIVE $350 MILLION IN PROCEEDS
    * ARYA SCIENCES ACQUISITION III CORP - INVESTORS IN PIPE
INCLUDE
LEAD INVESTOR PERCEPTIVE ADVISORS
    * ARYA SCIENCES ACQUISITION III - ASSUMING SHARE PRICE OF
$10 PER
SHARE, COMBINED CO IS EXPECTED TO HAVE INITIAL MARKET
CAPITALIZATION OF ABOUT $1.3 BILLION

Source text for Eikon:  ID:nBw6yvBzxa 
Further company coverage:  ARYA.O 

 ((Reuters.Briefs@thomsonreuters.com;))